Vasgene Therapeutics, Inc
3 clinical trials · Sponsor
◉ Watch Vasgene Therapeutics, Inc
| Record | Firm | Date |
|---|---|---|
| Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors (NCT06493552) | Vasgene Therapeutics, Inc | 2025-03-15 |
| A Study of sEphB4-HSA in Kaposi Sarcoma (NCT03993106) | Vasgene Therapeutics, Inc | 2020-09-17 |
| A Study of Pembrolizumab+ sEphB4 in Metastatic Urothelial Carcinoma (NCT04486781) | Vasgene Therapeutics, Inc | 2020-08-14 |
Track Vasgene Therapeutics, Inc automatically
Every clearance here is in the API, with alerts when new ones post.